is oral glp-1 as effective as injection Choosing vs. Injectable Semaglutide for Weight Loss Oral GLP-1 Pill Delivers Injection-Like

As a supplement, it is thought to be healthier than folic acid

Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) Injection site reactions Headache Fatigue Dizziness Important safety considerations include: Risk of hypoglycaemia when used with insulin or sulfonylureas (dose reduction of these agents may be needed) Potential worsening of diabetic retinopathy with semaglutide in patients with pre-existing retinopathy Risk of dehydration and acute kidney injury from persistent vomiting or diarrhoea Pancreatitis, gallbladder disease, and potential thyroid C-cell tumours (observed in rodent studies, though human relevance remains uncertain) Patients should be counselled about persistent severe abdominal pain as a potential warning sign of pancreatitis requiring immediate medical attention

PUFAs are esterified into PE via the ACSL4/LPCAT3 axis, forming peroxidation-susceptible PE-PUFA substrates (e.g., PE-AA/AdA)

They share common GI side effects, such as nausea, diarrhea, and vomiting